Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |